VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

Stock Comparison

WuXi AppTec Co., Ltd. vs Danaher Corporation

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

WuXi AppTec Co., Ltd.

603259 · Shanghai Stock Exchange

Market cap (USD)$37.4B
Gross margin (TTM)49.2%
Operating margin (TTM)42.7%
Net margin (TTM)41.7%
SectorHealthcare
IndustryMedical - Diagnostics & Research
CountryCN
Data as of2026-05-01
Moat score
72/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into WuXi AppTec Co., Ltd.'s moat claims, evidence, and risks.

View 603259 analysis

Danaher Corporation

DHR · New York Stock Exchange

Market cap (USD)$122.3B
Gross margin (TTM)60.7%
Operating margin (TTM)21%
Net margin (TTM)14.9%
SectorHealthcare
IndustryMedical - Diagnostics & Research
CountryUS
Data as of2026-05-27
Moat score
77/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Danaher Corporation's moat claims, evidence, and risks.

View DHR analysis

Comparison highlights

  • Moat score gap: Danaher Corporation leads (77 / 100 vs 72 / 100 for WuXi AppTec Co., Ltd.).
  • Segment focus: WuXi AppTec Co., Ltd. has 3 segments (84% in WuXi Chemistry); Danaher Corporation has 3 segments (40.6% in Diagnostics).
  • Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Moderate.
  • Moat breadth: WuXi AppTec Co., Ltd. has 5 moat types across 3 domains; Danaher Corporation has 7 across 3.

Primary market context

WuXi AppTec Co., Ltd.

WuXi Chemistry

Market

Global synthetic-molecule CRDMO services, including small-molecule discovery, process development, API manufacturing, peptides and oligonucleotides

Geography

Global, with major customer exposure to the United States, Europe and China

Customer

Large pharmaceutical companies, emerging biotechs and virtual pharma companies

Role

Integrated contract research, development and manufacturing partner across discovery, development and commercial manufacturing

Revenue share

84%

Danaher Corporation

Diagnostics

Market

In vitro diagnostics instruments, consumables, software and services (clinical lab, acute care/POC, pathology, molecular diagnostics)

Geography

Global

Customer

Hospitals, physician offices, reference laboratories, pathology labs, critical care settings

Role

IVD device manufacturer and reagent/test supplier + software/services

Revenue share

40.6%

Side-by-side metrics

WuXi AppTec Co., Ltd.
Danaher Corporation
Ticker / Exchange
603259 - Shanghai Stock Exchange
DHR - New York Stock Exchange
Market cap (USD)
$37.4B
$122.3B
Gross margin (TTM)
49.2%
60.7%
Operating margin (TTM)
42.7%
21%
Net margin (TTM)
41.7%
14.9%
Sector
Healthcare
Healthcare
Industry
Medical - Diagnostics & Research
Medical - Diagnostics & Research
HQ country
CN
US
Primary segment
WuXi Chemistry
Diagnostics
Market structure
Competitive
Oligopoly
Market share
6%-9% (implied)
n/a
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
72 / 100
77 / 100
Moat domains
Supply, Demand, Legal
Demand, Supply, Legal
Last update
2026-05-01
2026-05-27

Moat coverage

Shared moat types

Design In QualificationOperational Excellence

WuXi AppTec Co., Ltd. strengths

Scope EconomiesCapacity MoatCompliance Advantage

Danaher Corporation strengths

Installed Base ConsumablesService Field NetworkLearning Curve YieldRegulated Standards PipeSuite Bundling

Segment mix

WuXi AppTec Co., Ltd. segments

Full profile >

WuXi Chemistry

Competitive

84%

WuXi Testing

Competitive

9.3%

WuXi Biology

Competitive

6.2%

Danaher Corporation segments

Full profile >

Biotechnology

Oligopoly

30.2%

Life Sciences

Oligopoly

29.2%

Diagnostics

Oligopoly

40.6%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.